$591.25
Currently 21 wall-street analysts regularly analyze the financials of Madrigal Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 21 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals, Inc. (MDGL) have a share price target of $571.13. This median of share price forecast represents a -3.4% downside from the latest price of $591.25 as on 20.12.25.
As per the chart shown above, analysts believe that the Madrigal Pharmaceuticals, Inc. (MDGL) share price will touch around $571.13 in next 12-months.
Below is a chart showing the percentage difference between Madrigal Pharmaceuticals, Inc.'s share price and its median forecast price. As on 20.12.25, the difference is 1.46%
Based on 21 analysts tracking and researching Madrigal Pharmaceuticals, Inc. (MDGL) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 11 | 11 | 11 |
| Outperform | 5 | 6 | 6 |
| Hold | 3 | 3 | 3 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 1 |